论文部分内容阅读
目的:探讨经尿道等离子前列腺剜除术(TUPKEP)与经尿道等离子电切术(TUPKRP)治疗高危良性前列腺增生的临床疗效差异。方法:选取2014年1月~2015年12月本院泌尿外科采用手术治疗的72例高危良性前列腺增生患者进行回顾性分析,其中TUPKEP组37例、TUPKRP组35例,对比两组患者的手术情况、并发症及术后患者排尿情况。结果:TUPKEP组患者的手术时间、膀胱冲洗时间、前列腺切除重量、手术出血量、尿管留置时间、术后住院时间均显著的低于TUPKRP组患者,TUPKEP组患者的前列腺切除重量显著的高于TUPKRP组患者;术后3个月复查,TUPKEP组患者的IPSS评分、RUV、QOL显著的低于TUPKRP组患者,Qmax显著的高于TUPKRP组患者;术中,TUPKEP组患者的手术并发症率2.70%显著的低于TUPKRP组患者的8.57%;术后,TUPKEP组患者的手术并发症率45.95%显著的低于TUPKRP组患者的71.43%。结论:TUPKEP治疗高危良性前列腺增生较TUPKRP操作方便、快速,具有术后恢复快、手术效果好、并发症少的优势。
Objective: To investigate the clinical efficacy of transurethral plasmaphotonotomy (TUPKEP) and transurethral plasmakinectomy (TUPKRP) in the treatment of high-risk benign prostatic hyperplasia. Methods: From January 2014 to December 2015, 72 patients with high-risk benign prostatic hyperplasia (BPH) undergoing surgical treatment in urology department of our hospital were retrospectively analyzed. TUPKEP group (n = 37) and TUPKRP group (n = 35) , Complications and postoperative urination patients. Results: The operation time, bladder irrigation time, prostate resection weight, surgical bleeding volume, catheter indwelling time and postoperative hospital stay in TUPKEP group were significantly lower than those in TUPKRP group. The prostatectomy weight in TUPKEP group was significantly higher than that in TUPKEP group TUPKRP group; after 3 months of operation, the IPSS score, RUV and QOL in TUPKEP group were significantly lower than those in TUPKRP group, and Qmax was significantly higher in TUPKRP group than in TUPKRP group. The operative complication rate in TUPKEP group was 2.70 % Was significantly lower than 8.57% in TUPKRP group. The postoperative complication rate in TUPKEP group was 45.95%, which was significantly lower than 71.43% in TUPKRP group. Conclusion: TUPKEP is more convenient and rapid than TUPKRP in the treatment of high-risk benign prostatic hyperplasia. It has the advantages of rapid postoperative recovery, good operative effect and less complications.